|
🐜
|
Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene.
9 auth.
B. Lüdecke,
P. Knappskog,
Peter E. Clayton,
R. Surtees,
J. Clelland,
S. Heales,
...
M. Brand,
K. Bartholomé,
T. Flatmark
|
7 |
1996 |
7
🐜
|
|
🐬
|
Cell-matrix adhesions differentially regulate fascin phosphorylation.
J. Adams,
J. Clelland,
G. Collett,
F. Matsumura,
S. Yamashiro,
Linglan Zhang
|
7 |
1999 |
7
🐬
|
|
🐬
|
Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.
R. Surtees,
J. Clelland,
I. Hann
|
6 |
1998 |
6
🐬
|
|
🐢
|
Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome
8 auth.
Catherine L. Clelland,
L. Read,
Amanda N Baraldi,
Corinne P. Bart,
C. Pappas,
Laura J. Panek,
...
R. Nadrich,
J. Clelland
|
6 |
2011 |
6
🐢
|
|
🐜
|
Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
8 auth.
M. Richardson,
Margaret L. Bevans,
L. Read,
H. Chao,
J. Clelland,
R. Suckow,
...
T. Maher,
L. Citrome
|
5 |
2003 |
5
🐜
|
|
🐬
|
Analysis of Plasma Biopterin Levels in Psychiatric Disorders Suggests a Common BH4 Deficit in Schizophrenia and Schizoaffective Disorder
M. Richardson,
L. Read,
M. Reilly,
J. Clelland,
Catherine L. Clelland
|
5 |
2006 |
5
🐬
|
|
🐢
|
Evidence for a Tetrahydrobiopterin Deficit in Schizophrenia
8 auth.
Mary Ann Richardson,
L. Read,
Catherine L. Clelland,
M. Reilly,
H. Chao,
R. Guynn,
...
R. Suckow,
J. Clelland
|
5 |
2005 |
5
🐢
|
|
🐢
|
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort
Catherine L. Clelland,
K. Ramiah,
Louisa J. Steinberg,
J. Clelland
|
5 |
2021 |
5
🐢
|
|
🐢
|
Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile
Catherine L. Clelland,
L. Read,
Laura J. Panek,
R. Nadrich,
C. Bancroft,
J. Clelland
|
5 |
2013 |
5
🐢
|
